DIVISLAB — Divi's Laboratories Share News
0.000.00%
- IN₹3.04tn
- IN₹3.02tn
- IN₹105.60bn
India Stocks: Indian shares inch higher to close at 8-month high as crude oil drops
India's Divi's Laboratories jumps to record high after profit jumps by nearly two thirds
Indian shares muted as markets pause after last week's rally
India Stocks: Indian shares consolidate in Diwali session after seven-day rally
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
India's Divi's Laboratories rises to record high on quarterly profit jump
Street View: Brokerages flag margin headwinds for India's Divi's Laboratories
India's overseas M&A rush risks official ire
Indian contract drug maker Divi's misses profit view on high material costs, one-off labour charge
Brief: Divi's Laboratories Q3 Consol Net Profit 5.83 Billion Rupees
Indian contract drug makers to gain global share, says HDFC Securities
India's Divi's Laboratories up; Citi calls it their 'top pick'
Indian pharmas to benefit from potential US funding curbs on Chinese firms, Citi says
Brief: Divi's Labs Unit-I Inspection By US FDA Concluded
India's Divi Labs snaps six-session winning streak as investors book profits
Indian drugmaker Divi's beats profit view for second quarter on API boost
Brief: Divi's Labs Sept-Quarter Consol Net Profit 6.89 Billion Rupees
Indian contract research firms Divi's and Cohance gain as Jefferies bullish on sector
India's Divi's Labs drops on missing Q1 profit view